Frailty is a mortality risk factor in tafamidis-treated patients with transthyretin cardiac amyloidosis

Related

• Calf size and physical function predict heart failure mortality

  Archives of Gerontology and Geriatrics · 4 Oct 2026

• Metabolic signature links frailty to coronary artery disease

  The Journal of Nutrition, Health & Aging · 4 Oct 2026

  

• Multidisciplinary care reduces frailty in older cardiac patients

  Nature Communications · 4 Oct 2026

• Proteomic multi-organ aging accelerates before adverse events in heart failure patients

  European Journal of Heart Failure · 2 Oct 2026